A carregar...
Balancing Value with Affordability: Cell Immunotherapy for Cancer Treatment in the U.S.
Despite the Centers for Medicare and Medicaid Services’ recent approval to increase payments for inpatient‐delivered chimeric antigen receptor T‐cell therapy (CAR‐T) for adult lymphoma, reimbursement remains far below the costs of the product and overall treatment of the therapy. We surveyed 92 CAR‐...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356813/ https://ncbi.nlm.nih.gov/pubmed/32386072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0025 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|